SBIR/STTR Research Award

A single-strand ligation approach for concomitant DNA and RNA next-generation sequencing from low abundance inputs

Award identifier 76f457d491be7c6da79c94c3ce2e5321168e15f3f4597f2fc0d370446fee558bAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$224,396

Program and phase

SBIR · Phase I

Award year

2021

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
Claret Bioscience LLC
Proposal award date
2021-09-07
Contract end date
2022-08-31
UEI
NBKDPRMF8Y27
Solicitation number
PAR18-779
Topic code
172

Research abstract

PROJECT SUMMARYIntegrated genomic and transcriptomic analyses capture a wealth of information that can improve our understanding of normal biological phenomena and disease. Combining DNA and RNA next-generation sequencing (NGS) data from the same sample can improve predictive power of diagnostic and prognostic assays. However, performing multiomic analyses is often not feasible due to limited sample availability or low nucleic acid yields especially in single-cells and liquid biopsies. Extracellular nucleic acids derived from liquid biopsies such as plasma, urine and cerebrospinal fluid are increasingly used for rapid and non-invasive disease detection and treatment response monitoring in cancer and infectious diseases. An integrated protocol that captures both DNA and RNA can be of tremendous value in liquid biopsy-based diagnostics by saving precious clinical samples and reducing reagents requirement and sequencing costs.Traditional NGS library preparation methods for DNA and RNA have some overlap in protocol and typically utilize a common sequencing platform. However, these methods are cannot be adapted for simultaneous library generation due to substrate and enzymatic limitations. In contrast, Claret Bioscience’s innovative single-strand ligation approach facilitates direct library preparation from both RNA and DNA in three simplified steps. The method also adds nucleic acid-specific molecular barcodes which enable in silico deconvolution of DNA and RNA-derived sequences, making this method ideal for comprehensive NGS analyses.In this proposal, we seek to develop and optimize a concomitant DNA and RNA NGS library preparation protocol using a contrived mixture of fragmented human genomic DNA and yeast RNA along with spike-in controls (which serve as “ground truth”) as input. We will perform a series of experiments to test the efficacy of the protocol using a range of input amount and variable ratios of DNA and RNA to mimic the compositions frequently encountered in clinical samples. We will evaluate the stringency of adapter ligation using the nucleic acid-specific barcode and generate a user-friendly bioinformatic pipeline that will ultimately accompany the assay, for easy bioinformatic extraction of genomic and transcriptomic data from a given library. To evaluate protocol performance, we determine if the molecular, sequencing and mapping metrics of our method are equivalent to the metrics obtained with individual library preparation protocols, for both DNA and RNA. Finally, we will demonstrate biological utility of the method using our in-house repository of cell-free nucleic acids derived from healthy plasma samples. Successful accomplishment of these aims will generate a robust assay that simultaneously generates DNA and RNA NGS libraries within four hours. When combined with minimally invasive liquid biopsy-based approaches, the combinatorial NGS assay described here can significantly reduce financial and physical burden on the patient.PROJECT NARRATIVE DNA and RNA sequencing information improve our understanding of biological phenomena and can be used for better disease diagnosis and monitoring. Claret Biosciences proposes to develop a rapid and robust next-generation sequencing library preparation method that will allow simultaneous sequencing of both DNA and RNA from the same sample within 4 hours, in a single assay, thus reducing assay costs and saving time. This technology will be especially beneficial for testing samples such as single-cells and liquid biopsies that are present in limiting amounts or have very low concentration of nucleic acids and thus avoid separate assays for DNA and RNA.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

4 SBIR/STTR records share this UEI (2018–2024). Reported award amounts total $1,181,452. Reported amounts are not federal obligations.

Phases: Phase I

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.